Vasculitis (Vasculitides) Summary

Networked: 8562 relevant articles (437 outcomes, 487 trials/studies) for this Disease

Key Drugs and Agents for Vasculitis

1. Antineutrophil Cytoplasmic Antibodies (ANCA) : 89 outcomes 121 studies in 1797 results : IBA
   
2. Cyclophosphamide (Cytoxan) : 64 outcomes 24 studies in 260 results : FDA 10 Generic
   
3. glucuronyl glucosamine glycan sulfate (Vessel) : 45 outcomes 71 studies in 1880 results : IBA
   
4. rituximab (Mabthera) : 37 outcomes 25 studies in 164 results : FDA 3
   
5. Adrenal Cortex Hormones (Corticosteroids) : 33 outcomes 4 studies in 169 results : IBA
   
6. Azathioprine (Imuran) : 19 outcomes 8 studies in 55 results : FDA 7 Generic
   
7. Antigen-Antibody Complex (Immune Complex) : 14 outcomes 31 studies in 545 results : IBA
   
8. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor) : 14 outcomes 4 studies in 90 results : IBA
   
9. Methotrexate (Mexate) : 13 outcomes 5 studies in 57 results : FDA 8 Generic
   
10. Steroids : 12 outcomes 4 studies in 98 results : IBA
    

Diseases Related to Vasculitis

1. Wegener Granulomatosis (Wegener's Granulomatosis)
2. Infection
3. Inflammation
4. Glomerulonephritis
5. Systemic Lupus Erythematosus (Libman-Sacks Disease)

Key Therapies for Vasculitis

1. Plasma Exchange : 12 outcomes 11 studies in 71 results
   
2. Aftercare (After-Treatment) : 7 outcomes in 37 results
   
3. Transplants (Transplant) : 6 outcomes 2 studies in 118 results
   
4. Drug Therapy (Chemotherapy) : 6 outcomes in 63 results
   
5. Plasmapheresis : 4 outcomes 4 studies in 45 results